Bayesian Network Meta-Analysis of the Effectiveness of Various Interventions for Nontraumatic Osteonecrosis of the Femoral Head

Table 1

Design and characteristics of randomized controlled trials (RCTs) included in the Bayesian network meta-analysis.

N	Author	Year	NCT register	Comparisons (Group A vs Group B)	No. of patients	No. of Hips	Mean age	Stage of patients	Follow-up,; months
1	Asser A. Sallam	2017	NA	CD vs IFHG	61	A:38; B:33	A:33.21 ± 8.79; B:32.76 ± 8.16	Ficat I -III	94.32(36-168)
2	Cao	2017	NA	DD vs FVFG	21	42	31±6(21–48)	ARCO I - III	6,12,24,36
3	S. P. Mohanty	2016	NA	DD vs FVFG	46	69	35.38±7.55	Ficat I – III	3,6,12,24
4	Miao	2015	NA	DD vs TI	A:30; B:30	A:34; B:36	A:35.2±5.8; B:32.6±6.3	Steinburg I -II	A:18.1±5.2; B:19.8±4.1
5	Abdullah Al Omran	2013	NA	CD vs DD	A:61; B:33	A:61; B:33	26 (15-33)	Ficat I -I II	3,6,12,24
6	Cihangir TETIK	2011	NA	VFG vs FVFG	A:8; B:13	A:11; B:15	A:34(30-40); B:34 (17–66)	Ficat II-IV	A:22(12-57); B:42(16–114)
7	Cheng-Yo Yen	2006	NA	FVFG vs VIPBG	A:22; B:33	A:22; B:39	A: 38(28-52); B: 40(26–63)	Steinburg I-IV	A:36 B:48
8	Wang	2005	NA	ESW vs FVFG	A:23; B:25	A:29; B:28	A:39.8 ± 12.1(19-63); B:39.9 ± 9.3(19-53)	ARCO I-III	A: 25.2 ± 3.7 (24-38) B: 25.8 ± 4.6 (24-39)
9	SHIN-YOON KIM	2005	NA	VFG vs FVFG	A:19; B:23	A:19; B:23	A:43(24-52); B:44(23-51)	Steinburg II-IV	A:50(36-66); B:50(36-67)
10	ANTON Y.PLAKSEYCHUK	2003	NA	VFG vs FVFG	A:50; B:50	A:50; B:50	A:44(23-52); B:44(16-67)	Pittsburgh I-III	A:60 B:60
11	Hans-Georg Simank	2001	NA	Osteotomy vs CD	A:67; B:74	A:83; B:94	A:42(21-60); B:40(16-77)	Steinburg I -V	A:72 B:72
12	Scully SP	1998	NA	VFG vs CD	A:480; B:72	A:614; B:98	A:35(18-60); B:41(18-66)	Ficat I-III	A:50 B:50
13	KYUNG-HOI KOO	1995	NA	CD vs VFG	33	A:19; B:18	47(18-68)	Steinburg I-III	24
14	Steve M	1993	NA	CD vs FVFG	A:15; B:19	A:19; B:20	42(26-48)	Ficat II-III	24(24-60)